Skip to main content

Hearing Intervention May Have Effect on Cognitive Change

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

THURSDAY, July 20, 2023 -- A hearing intervention did not reduce three-year cognitive decline in a total cohort composed of two populations, but the intervention protected against cognitive decline in a population of older adults at greater risk for dementia, according to a study published online July 17 in The Lancet to coincide with the annual Alzheimer's Association International Conference, held from July 16 to 20 in Amsterdam.

Frank R. Lin, M.D., from the Johns Hopkins Cochlear Center for Hearing and Public Health in Baltimore, and colleagues conducted a randomized controlled trial of adults aged 70 to 84 years with untreated hearing loss and without substantial cognitive impairment. Participants were recruited from two study populations: older adult participants in an Atherosclerosis Risk in Communities (ARIC) study, who had more risk factors for cognitive decline and lower cognition scores at baseline, and healthy de novo volunteers. Participants were randomly assigned to a hearing intervention (audiological counseling and provision of hearing aids) or a control intervention of health education (490 and 487 individuals, respectively).

The researchers found that in the primary analysis combining the ARIC and de novo cohorts, three-year cognitive change did not differ significantly between the groups (−0.200 and −0.202 in the hearing intervention and control groups, respectively). A significant difference was seen in the effect of the hearing intervention on three-year cognitive change between the ARIC and de novo cohorts in a prespecified sensitivity analysis (three-year cognitive change in the ARIC cohort, –0.213 and –0.151 standard deviation units in the intervention and control groups, respectively). The results were not altered in other prespecified sensitivity analyses that varied analytical parameters used in the total cohort.

"Hearing loss might be a particularly important global public health target for dementia prevention efforts given that hearing loss is highly prevalent among older adults and is treatable with an established intervention," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

More Information

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

Read this next

Bilateral Gene Therapy Safely Restores Hearing in Children Born Deaf

WEDNESDAY, June 5, 2024 -- For pediatric patients with autosomal recessive deafness 9 (DFNB9), bilateral gene therapy with adeno-associated virus (AAV) serotype 1 carrying human...

Study Looks at Links Between Cognition, Psychopathology, Weight in Preteens

WEDNESDAY, June 5, 2024 -- Lower cognition and greater psychopathology at baseline are associated with increased weight gain for children entering adolescence, according to a...

Cochlear Implants Aid Meniere Disease Outcomes

TUESDAY, June 4, 2024 -- Cochlear implantation (CI) positively impacts hearing, vertigo, tinnitus, and quality of life in patients with Meniere disease (MD), according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.